Therefore, the concept of the beneficial effect of inhibition of survivin in experimental PAH is well demonstrated, and now in this study in a more robust experimental model than that of rat exposed to monocrotaline or hypoxia. The gene discussed is BIRC5; the disease is pulmonary arterial hypertension.